FREGAT Trial (2019): Minimally Invasive Esophagectomy for Esophageal Cancer
FREGAT Trial Key Points
- Minimally invasive esophagectomy (MIE) was found to have significantly lower complications and side effects compared to open esophagectomy.
- The 3 years survival rate was also higher among patients undergoing minimal invasive esophagectomy.
- Open esophagectomy is known to have significant morbidity ranging from 17.9% to 58%, with up to 6% mortality. Therefore, the minimally invasive hybrid procedure is now being utilized to limit the adverse events.
Want to read more posts?